These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19733449)

  • 1. Working memory deficits predict short-term smoking resumption following brief abstinence.
    Patterson F; Jepson C; Loughead J; Perkins K; Strasser AA; Siegel S; Frey J; Gur R; Lerman C
    Drug Alcohol Depend; 2010 Jan; 106(1):61-4. PubMed ID: 19733449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline improves mood and cognition during smoking abstinence.
    Patterson F; Jepson C; Strasser AA; Loughead J; Perkins KA; Gur RC; Frey JM; Siegel S; Lerman C
    Biol Psychiatry; 2009 Jan; 65(2):144-9. PubMed ID: 18842256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
    Ashare RL; McKee SA
    Exp Clin Psychopharmacol; 2012 Feb; 20(1):63-70. PubMed ID: 21942262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
    Hajek P; Tønnesen P; Arteaga C; Russ C; Tonstad S
    Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A
    Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-validation of a new procedure for early screening of smoking cessation medications in humans.
    Perkins KA; Lerman C; Fonte CA; Mercincavage M; Stitzer ML; Chengappa KN; Jain A
    Clin Pharmacol Ther; 2010 Jul; 88(1):109-14. PubMed ID: 20485335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of varenicline on abstinence and smoking reward following a programmed lapse.
    McClure EA; Vandrey RG; Johnson MW; Stitzer ML
    Nicotine Tob Res; 2013 Jan; 15(1):139-48. PubMed ID: 22573730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence.
    Perkins KA; Mercincavage M; Fonte CA; Lerman C
    Psychopharmacology (Berl); 2010 May; 210(1):45-51. PubMed ID: 20306175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.
    Agboola SA; Coleman T; McNeill A; Leonardi-Bee J
    Addiction; 2015 Jul; 110(7):1182-93. PubMed ID: 25846123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
    West R; Baker CL; Cappelleri JC; Bushmakin AG
    Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.